RecruitingNot ApplicableNCT05711888
Semantic Recognition Task (SRT) in Alzheimer Disease
A Sensitive Measurement Proposal in Alzheimer's Disease: Semantic Recognition Task
Sponsor
Istanbul University
Enrollment
80 participants
Start Date
Dec 21, 2022
Study Type
INTERVENTIONAL
Conditions
Summary
The goal of this study is to observe the outcomes of a semantic recognition task in Alzheimer Disease and discuss what this might add to clinical practice.
Eligibility
Inclusion Criteria1
- to have biomarker analysis for Alzheimer disease (positive or negative).
Exclusion Criteria1
- illiteracy
Interventions
BEHAVIORALSemantic Recognition Procedure
A semantic recognition task is going to be added to administrated FCSRT procedure after immediate and delayed recall phases.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05711888
Related Trials
Novel Augmentation of DAOIB and Antioxidant for Early Dementia
NCT064675391 location
A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)
NCT06937229241 locations
Psilocybin for Depression in People With Mild Cognitive Impairment or Early Alzheimer's Disease
NCT041233141 location
Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease
NCT071782101 location
A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
NCT06585787278 locations